Hg announces investment in the Access Group – Hg, which maaged the Manager of HgCapital Trust (HGT) has announced today an investment in The Access Group. It is one of the UK’s leading providers of business management software to mid-market companies. HgCapital will invest approximately £30.9 million in Access, with other institutional clients of Hg investing alongside the […]
NB Global Floating Rate performs well in a difficult year – NB Global Floating Rate (NBLS) targets income generation whilst seeking to preserve investors’ capital and give protection against rising interest rates. The year to 31 December 2017 again proved to be eventful not just in geopolitical or macroeconomic terms. United States and European senior secured floating […]
Underweight Chinese tech companies detract from Aberdeen Asian Income – Aberdeen Asian Income’s NAV returned 16.0% in sterling terms, compared to the MSCI All Countries Asia Pacific ex Japan Index, which returned 25.4%. The ordinary share price total return was 17.4% while the discount to NAV narrowed slightly to 7.5% at the year end. A […]
RDI £26m disposal in Leeds – RDI the UK real esrate investment trust (REIT) has exchanged contracts for the disposal of City Point in Leeds for £26.05 million. The property, which has been acquired by West Midlands Pension Fund, delivers total gross annualised rental income of £1.6 million with a WAULT of 3.7 years. According to LDI […]
Standard Life Property Income completed disposal – Standard Life Investments Property Income Trust (SLIPIT) has completed the sale of a multi let office in Slough for £13.25m, 9.6% ahead of the end December valuation. In the release, the manger commented that the sale proceeds will be reinvested when suitable opportunities are available. The disposal is to realise […]
Industrial sector contributes to Standard Life Property Income’s performance – The portfolio total return of Standard Life Property Income (SLI) was 12.1% representing a significant margin over the benchmark return. This outperformance was driven by an above benchmark portfolio income return of 6.3% and a capital return of 5.5%. The capital return was achieved despite the drag […]
BB Biotech may have to take hit on Incyte stake Switzerland’s BB Biotech (BBB.S) looks set to be in for a difficult month in terms of performance as a result of the negative result reported in a Phase III trial of a drug from Incyte Pharmaceuticals (Nasdaq:INCY), which was the trust’s third largest holding accounting […]
Syncona sees slight dip in NAV as Nightstar declines UK hybrid biotech investor/fund-of-funds Syncona (SYNC) saw a 0.8% fall in its NAV in February according to its latest factsheet, principally as a result of an 8% decline in the value of its holding in US-listed Nightstar Therapeutics. Syncona holds a 42% stake in this Nasdaq-quoted, but UK […]
Juridica left with seven cases – During 2017, Juridica’s NAV per share dropped by US$0.0977 per share from US$0.2541 per share at 31 December 2016 to US$0.1563 per share at 31 December 2017. mostly this relates to the payment of dividends amounting to US$11.9 million (US$0.1074 per share) but it also made a profit during 2017 of US$1.1 million (US$0.0097 per […]
NB Private Equity Partners dollar gains wiped out by sterling strength – The highlights from NB Private Equity’s results for 2017 are: 31 December 2017 Net Asset Value per share of $17.45 increased $1.54 from $15.91 at 31 December 2016. However, in sterling term the move translated to a 2p rise from GBP12.89 to GBP12.91 NAV total return of 13.2% NAV increase […]
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
Due to data protection policies, USA residents can not access our data.
Your content has been curated
